Africa (WHO region) vs Montenegro: HIV-positive TB patients on ART (antiretroviral therapy)
Africa (WHO region)
96.0%
in 2024
Montenegro
100.0%
in 2023
Africa (WHO region) rank
2nd
Montenegro rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Africa (WHO region)
- Montenegro
How they compare
Montenegro currently reports 100.0% against 96.0% in Africa (WHO region), a difference of 4.0%.
The two have swapped places 2 times across 6 shared years of data; in 2006 it was Montenegro ahead.
Africa (WHO region) ranks 2nd and Montenegro ranks 1st of 11 groups.
Across the 3 decades both report, Africa (WHO region) averaged higher in 1 and Montenegro in 2.
Head to head by decade
| Decade | Africa (WHO region) | Montenegro | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 44.0% | 100.0% | 56.0% | Montenegro |
| 2010s | 66.3% | 100.0% | 33.7% | Montenegro |
| 2020s | 93.5% | 75.0% | 18.5% | Africa (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Africa (WHO region) or Montenegro?
- Montenegro, at 100.0% against 96.0% in Africa (WHO region) as of 2023.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Africa (WHO region) and Montenegro?
- 4.0%, with Montenegro ahead.
- How many years of comparable data are there for Africa (WHO region) and Montenegro?
- 6 years are reported by both, from 2006 to 2023.
- How do Africa (WHO region) and Montenegro rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Africa (WHO region) ranks 2nd and Montenegro ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.